The feel-good place to buy books
Data Analysis with Competing Risks and Intermediate States by Ronald B Geskus
Data Analysis with Competing Risks and Intermediate States explains when and how to use models and techniques for the analysis of competing risks and intermediate states. It covers the most recent insights on estimation techniques and discusses in detail how to interpret the obtained results.
After introducing example studies from the biomedical and epidemiological fields, the book formally defines the concepts that play a role in analyses with competing risks and intermediate states. It addresses nonparametric estimation of the relevant quantities. The book then shows how to use a stacked data set that offers great flexibility in the modeling of covariable effects on the transition rates between states. It also describes three ways to quantify effects on the cumulative scale.
Each chapter includes standard exercises that reflect on the concepts presented, a section on software that explains options in SAS and Stata and the functionality in the R program, and computer practicals that allow readers to practice with the techniques using an existing data set of bone marrow transplant patients. The book’s website provides the R code for the computer practicals along with other material.
For researchers with some experience in the analysis of standard time-to-event data, this practical and thorough treatment extends their knowledge and skills to the competing risks and multi-state settings. Researchers from other fields can also easily translate individuals and diseases to units and phenomena from their own areas.
-
R for Health Technology Assessment
-
Value of Information for Healthcare Decision-Making
-
Bayesian Models in Health Technology Assessment
-
Statistical Methods for Immunogenicity Assessment
-
Randomization, Masking, and Allocation Concealment
-
Exposure-Response Modeling
-
Mixture Modelling for Medical and Health Sciences
-
Statistics In the Pharmaceutical Industry
-
Design and Analysis of Bioavailability and Bioequivalence Studies
-
Mixed Effects Models for the Population Approach
-
Multiple Testing Problems in Pharmaceutical Statistics
-
Machine Learning for Microbiome Statistics
-
Master Protocol Clinical Trials for Evidence Generation
-
Does This Treatment Cause That Outcome?
-
Comparative Effectiveness and Personalized Medicine Research Using Real-World Data
-
Age-Period-Cohort Models
-
Biostatistics for Bioassay
-
Statistical Methods for Survival Trial Design
-
Every Coin Has Two Sides
-
Group Sequential and Adaptive Methods for Clinical Trials
-
Empirical Likelihood Method in Survival Analysis
-
Multiregional Clinical Trials for Simultaneous Global New Drug Development
-
Adaptive Design Methods in Clinical Trials
-
Clinical Trial Data Analysis Using R and SAS
-
Bayesian Cost-Effectiveness Analysis of Medical Treatments
-
Statistical Methods for Drug Safety
-
Emerging Non-Clinical Biostatistics in Biopharmaceutical Development and Manufacturing
-
Design & Analysis of Clinical Trials for Economic Evaluation & Reimbursement
-
Meta-Analysis in Medicine and Health Policy
-
Model-Assisted Bayesian Designs for Dose Finding and Optimization
-
Statistical Methods in Drug Combination Studies
-
Design and Analysis of Clinical Trials for Predictive Medicine
-
Frailty Models in Survival Analysis
-
Bayesian Methods in Health Economics
-
Survival Analysis in Medicine and Genetics
-
Clinical Trial Methodology
-
Applied Surrogate Endpoint Evaluation Methods with SAS and R
-
Repeated Measures Design with Generalized Linear Mixed Models for Randomized Controlled Trials
-
Design and Analysis of Animal Studies in Pharmaceutical Development
"… a useful read for anyone wanting to apply competing risks or multi-state methodsThe examples used throughout the book make the methods clinically meaningful for anyone wanting to simply grasp the concepts behind the methods, and the mathematical theory is rigorously described for those wanting a more in-depth understanding. The book is also supported by a website (http://www.competingrisks.org), which holds additional tips and R code to supplement the exercises at the end of each of the five chapters."
—Journal of Biopharmaceutical Statistics, 2015
"This book is excellent for applied statisticians working with time-to-event data."
—James J. Dignam, Department of Public Health Sciences, The University of Chicago
"An accessible introduction to the theory of competing risks and multistate models."
—Sandra Eloranta, Karolinska Institutet
"This book is about the particular context of competing risks and intermediate states. These risks or states have often been ignored in survival analysis but the situation is changing rapidly. The book is well written. Basic concepts of survival analysis are recalled and the reader is brought to the most complex concepts. Thus the book can be read both by beginners or experts in survival analysis. The reader can easily skip chapters that are not relevant according to his expertise and usefulness."
—International Society for Clinical Biostatistics
Ronald B. Geskus is an associate professor at the Academic Medical Center in Amsterdam. He received a Ph.D. in mathematics from the Delft Technical University. His main research interests include competing risks and multi-state models, prediction of events based on time-updated marker values, and causal inference.
| SKU | Unavailable |
| ISBN 13 | 9781466570351 |
| ISBN 10 | 1466570350 |
| Title | Data Analysis with Competing Risks and Intermediate States |
| Author | Ronald B Geskus |
| Series | Chapman And Hall Crc Biostatistics Series |
| Condition | Unavailable |
| Binding Type | Hardback |
| Publisher | CRC Press LLC |
| Year published | 2015-07-14 |
| Number of pages | 277 |
| Cover note | Book picture is for illustrative purposes only, actual binding, cover or edition may vary. |
| Note | Unavailable |






































